# Strides Pharma Inc. – FDA Inspection, Feb 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/strides-pharma-inc/67bd5a17-2b99-4ef7-a207-b051b6dcb023
Source feed: FDA_Inspections

> FDA inspection 1230104 of Strides Pharma Inc., February 16, 2024. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 314. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1230104
- Company Name: Strides Pharma Inc.
- Inspection Date: 2024-02-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Surv. and Epidemiology
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1049638 - 2018-04-18](https://www.keypedia.com/records/fda_inspections/strides-pharma-inc/df800a9c-7a50-4b81-9326-f3634cb12ee5)

## Related Officers

- [Investigator](https://www.keypedia.com/people/mayar-m-mussa/4f39b1c8-93a6-4bc9-a800-5f802db48be6)

Company: https://www.keypedia.com/companies/strides-pharma-inc/abe8bf9f-6560-4c11-91b3-dbe915203b9c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c